Recurrence of Thymoma with Appearance of Myasthenia Gravis 18 Years after Surgery: A Case Report
Tetsu Shinkai(National Cancer Center), YUKIO SHIMOSATO(National Cancer Research Institute), Takashi Nakajima(Saigata National Hospital), Hiroshi Hasegawa(Shibaura Institute of Technology), KEIICHI SUEMASU(National Cancer Center), N Miyazawa(National Cancer Center), TOMOYOSHI KAMIYA(Nippon Koei (Japan)), S Yoshioka(National Cancer Center), Nagahiro Saijo(National Cancer Center Hospital East), Fumihiko Kanzawa(National Cancer Research Institute)
Cited by 15
Related Papers
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
|New England Journal of Medicine|2009|8.2k
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
Natural history of hepatocellular carcinoma and prognosis in relation to treatment study of 850 patients
|Cancer|1985|1.9k
Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)
|Journal of Clinical Oncology|2011|1.6k
Ultrasonically guided subsegmentectomy.
|PubMed|1985|823